Personalized Stem Cells: Our Drive to Legitimize Stem Cell Therapy
Personalized Stem Cells is committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients.
Personalized Stem Cells Receives FDA Approval to Treat COVID-19 Patients in Clinical Trial
Personalized Stem Cells (PSC) recently received FDA approval to treat COVID-19 patients with stem cells in an upcoming clinical trial.
Update from Personalized Stem Cells: COVID-19 and More
The COVID-19 pandemic has changed our way of life these past few months. The Personalized Stem Cells team has been working hard to continue manufacturing stem cell doses for current and potential clinical trial participants.
Personalized Stem Cells is raising the standard of Stem Cell therapy
Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and...
Can Stem Cell Therapy Help Patients Avoid Knee Surgery?
Personalized Stem Cells’ (PSC) clinical trial may provide data to help determine if treatment with stem cells may help patients avoid knee replacement surgery.
PSC Medical Director Speaks at Virtual TOBI Conference on Stem Cells for COVID-19
PSC Medical Director, Dr. Christopher Rogers, recently spoke at the annual TOBI conference on mesenchymal stem cells for the treatment of COVID-19.
Stem Cell Storage: Planning for Your Future
PSC stores adipose (fat) derived stem cells from clinical trial participants in our FDA-inspected facility. Stored stem cells can potentially be used to treat future approved conditions.
FDA Approved Stem Cell Clinical Trials
Stem cell therapies have many potential uses. If seeking treatment with stem cells, it is advisable to confirm FDA oversight of the treatment or clinical trial.
Meet PSC Medical Director, Dr. Christopher Rogers
Dr. Christopher Rogers is the Medical Director of Personalized Stem Cells, Inc. An expert in Regenerative Medicine with more than twenty-five years of clinical experience, Dr. Rogers is one of the investigators in PSC’s first FDA approved clinical trial.
Interview with CBS Affiliate Regarding Stem Cells for COVID-19
On April 27, 2020 PSC CEO, Dr. Bob Harman and PSC Medical Director, Dr. Christopher Rogers, were interviewed by San Diego CBS affiliate, KFMB TV, regarding stem cell therapy for COVID-19.